Products(0)
Home > All Categories > Health & Medicine » Pharmaceutical Chemicals

API Nintedanib powder CAS No 656247-17-5 manufacture

Unit Price:Get Latest Price
Payment Type: L/C,T/T,D/P
Incoterm: FOB,CIF
Min. Order: 0.01 Kilogram
Delivery Time: 7 Days
Transportation: Ocean,Air
Port: Shanghai,Shenzhen,Qingdao

Your message must be between 20 to 2000 characters

Ms. Lily
  • Product Details
  • Company Profile

Product Description

  • Model No.: DM 656247-17-5
  • Function: Specialist Drugs
  • Certification: FDA, SGS, GMP
  • Grade Standard: Medicine Grade
  • Type: Chemical Reagent
  • State: Solid
  • Volatile: Not Volatile
  • Purity: 99%
  • Appearence: Yellow Powder
  • Packaging: As required

Manufactuere supply API Nintedanib powder CAS No 656247-17-5:

Name : Nintedanib, CAS 656247-17-5
Chemical name :

methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate Nintedanib

Key words : API; antineoplastic; treat idiopathic pulmonary fibrosis.
CAS NO.    : 656247-17-5

EINECS No:1592732-453-0
Molecular Formula : C31H33N5O4
Molecular Weight : 539.636 g/mol 

We are the manufacturer of Nintedanib and its intermediates, high purity, low price, stock available


Nintedanib is an oral administrated triple tyrosine kinase inhibitors developed by Boehringer Ingelheim, Germany. Its targets include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and basic fiber (BFGF), being able to also inhibit the activation of MAPK and Akt. At present, it is mainly used for cancer treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. The study regarding to the respiratory diseases mainly focuses on the clinical treatment of advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF). In June 2014, Boehringer Ingelheim has announced that the marketing authorization application of Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF) had been confirmed by the European Medicines Agency (EMA) and been included in the accelerated approval list by the EMA.

Treatment of systemic sclerosis.
Treatment of idiopathic pulmonary fibrosis.
Argatef is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.


Our productions of Nintedanib Intermediates:

Nintedanib Intermediates


Picture of Nintedanib powder CAS No 656247-17-5:

Nintedanib powder CAS No 656247-17-5

Package & Shipping:

1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping for 100KG above; Sea shipping for quantity over 500KG.
2. We can offer the complete package from concept to delivery; arranging everything up until products arrive at your own door or distribution hub.
    Delivery can be offered.
  - Utilizing your own freight-forwarder
  - FOB to a port in China
  - CIF to a port near you

Nintedanib powder


Our Service:

1. Supply high quality products with reasonable prices for pharmaceutical factory. 
2. In time delivery, Packing pictures and loading video before loading.
3. Various documents(COA, MSDS, ROS, MOA etc.) and factory audit available. 
4. Pre-sale consultation and post-sale service available.
5. Provide market informations to make customers fully informed.


Company Information:

Shijiazhuang Dingmin Pharmaceutical Sciences Co., Limited is a professional company ocusing on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. We have a R&D center and two plants in Shijiazhuang, Hebei Province. Our Products include active pharmaceutical ingredients (API), pharmaceutical and agrochemical intermediates and chiral compounds. We have won the trust of a wide range of customers/partners in the industry. Our major products are antineoplastic, cardiovascular and antibiotics and their intermediates.
In order to maintain continuous innovation and R & D capability, we maintain long-term and close cooperation with many research institutions and universities, Our co-production plants are located in Anhui, Jiangsu, Zhejiang and Inner Mongolia. The products have been sold to Europe, America, Southeast Asia and other countries and regions
Having upholding the " integrity, profession , innovation, win-win" as business philosophy, we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors to co-create a brilliant tomorrow together.

CAS No 656247-17-5


Related Keywords
Shijiazhuang Dingmin Pharmaceutical Sciences Co., Limited is a professional company focusing on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. We have a R&D center and two plants in Shijiazhuang, Hebei Province. Our Products include active pharmaceutical ingredients (API), pharmaceutical and agrochemical intermediates and chiral compounds. We have won the trust of a wide range of customers/partners in the industry. Our major products are antineoplastic, cardiovascular and antibiotics and their intermediates.
In order to maintain continuous innovation and R & D capability, we maintain long-term and close cooperation with many research institutions and universities, Our co-production plants are located in Anhui, Jiangsu, Zhejiang and Inner Mongolia. The products have been sold to Europe, America, Southeast Asia and other countries and regions
Having upholding the " integrity, profession, innovation, win-win" as business philosophy, we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors to co-create a brilliant tomorrow together.

Basic Information

  • Company Name:

    Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

  • Representative:

    WANGGUOZHANG

  • Business Type:

    Manufacturer , Trade Company

  • Product/Service:

    API , Raw Material Pharma , Pharmaceutical Intermediates , Active Pharmaceutical Ingredients , Agrochemical Intermediates , Fine Chemicals

  • No. of Total Employees:

    5~50

  • Capital (Million US $):

    1000,000RMB

  • Year Established:

    2014

  • Product Range:

    Pharmaceutical Chemicals , Pharmaceutical Intermediate

  • Certificate:

    Manufacturer , Trade Company

  • Company Address:

    No.41 Zhaiying South Street,Yuhua District

Trade & Market

  • Total Annual Sales Volume (Million US $):

    US$2.5 Million - US$5 Million

  • Export Percentage:

    81% - 90%

  • Total Annual Purchase Volume (Million US $):

    US$1 Million - US$2.5 Million

  • Main Markets:

    Americas , Asia , Europe , North Europe , West Europe , East Europe , Oceania , Worldwide , Other Markets

Factory Information

  • No. of Production Lines:

    2

  • No. of R&D Staff:

    11 -20 People

  • No. of QC Staff:

    5 -10 People

  • OEM Services Provided:

    yes

  • Factory Size (Sq.meters):

    50,000-100,000 square meters

  • Factory Location:

    Nanpiao Circular Industrial park ,Huludao City, Liaoning Province,China

Other products from this company More
Email to this supplier
  • *To:
    Ms. Lily
  • *Messages:
    Your message must be between 20-8000 characters
  • *Quantity:

Categories: Nintedanib Intermediates

Business type:Manufacturer,Trade Company

Certification:ISO9001,CCC,FDA,MSDS,FCC,REACH,RoHS

OEM service:yes

Contact Supplier

Ms. Lily
Contact Now

Not exactly what you want?

Get the latest products & offers on

Nintedanib Intermediates